Breast cancer should not show up in women in their 20s and 30s. But it does. And the disease shouldn't be more deadly in younger women than it is in older women. But it is. The trends for these sad facts aren’t looking good.

Herceptin (trastuzumab) is a leading medication used to treat a particularly aggressive form of breast cancer, known as HER2-positive. Researchers are now suggesting the medicine may be useful in treating other forms of breast cancer.

Many hospital labor and delivery units have staff on the floor on an as-needed basis. Others employ a new model of round-the-clock staffing. There may be good reason for the new model.

Loads of health problems have been linked to obesity in recent medical studies. Fortunately, ovarian cancer and obesity don't necessarily go hand-in-hand.

If it didn't work the first time, women who get urinary slings to control their bladder can certainly try the procedure again. The second or third time might be a charm, but not all outcomes with the new slings benefit its user.

Robot technology is being used in surgical settings, but can cost a pretty penny. If two surgeries are equally safe, the less expensive procedure may be best.

Deploying overseas in the military can be stressful for any soldier. So one could imagine it may be even rougher for women who deploy after having a baby.

People might say out of frustration “I feel fat” or “I feel old.” But for women with eating disorders these types of comments may signal a fixation on young, thin, ideal body images.

Patients with HER2-positive breast cancer have a new medication to treat the disease in its late stages, after it has started to spread.